F. Jansman
发表
A. Jager,
R. Mathijssen,
T. van Gelder,
2014,
Annals of oncology : official journal of the European Society for Medical Oncology.
R. Mathijssen,
T. van Gelder,
R. V. van Leeuwen,
2015,
Annals of oncology : official journal of the European Society for Medical Oncology.
R. Mathijssen,
T. van Gelder,
R. V. van Leeuwen,
2014,
The Lancet. Oncology.
J. ten Oever,
R. ter Heine,
F. Jansman,
2019,
International journal of antimicrobial agents.
D. Sleijfer,
J. Brouwers,
F. Jansman,
2001,
Drug safety.
J. Brouwers,
L. J. D. Berg,
F. Jansman,
2017
.
R. V. van Lingen,
L. de Jong-van den Berg,
J. Brouwers,
2008,
Obstetrical & gynecological survey.
C. V. van Herpen,
W. van Boxtel,
N. V. van Erp,
2021,
International journal of cancer.
F. Jansman,
2010
.
M. Postma,
F. Jansman,
2006,
The European Journal of Health Economics.
F. Jansman,
2005
.
K. Taxis,
I. R. F. van Berlo-van de Laar,
C. G. Vermeij,
2022,
European Journal of Clinical Pharmacology.
K. Taxis,
I. R. F. van Berlo-van de Laar,
F. Jansman,
2021,
Pharmacology research & perspectives.
Y. Assaraf,
A. Dingemans,
R. Mathijssen,
2022,
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
R. Mathijssen,
T. van Gelder,
R. V. van Leeuwen,
2019,
Therapeutic advances in medical oncology.
R. Mathijssen,
R. V. van Leeuwen,
K. Hussaarts,
2020,
The Lancet. Oncology.
M. Postma,
J. Brouwers,
F. Jansman,
2017
.
N. Veeger,
E. V. van Roon,
J. A. Kroes,
2021,
Supportive Care in Cancer.
W. Vervenne,
H. Gelderblom,
W. T. van der Graaf,
2021,
International journal of cancer.
R. ter Heine,
P. D. de Reuver,
A. Bremers,
2018,
British journal of clinical pharmacology.
R. V. van Lingen,
L. de Jong-van den Berg,
B. Wilffert,
2012,
British journal of clinical pharmacology.
W. M. Smit,
D. Sleijfer,
J. Brouwers,
2005,
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
D. Tibboel,
N. Holford,
B. Anderson,
2003,
European Journal of Clinical Pharmacology.
C. V. van Herpen,
D. Burger,
N. V. van Erp,
2019,
The Lancet. Oncology.
D. Burger,
N. V. van Erp,
F. Jansman,
2019,
Biomedical chromatography : BMC.
J. Brouwers,
N. H. Prins,
C. Neef,
2006,
Therapeutic drug monitoring.
D. Sleijfer,
J. Brouwers,
Jacobus R.B.J. Brouwers,
2000,
Drug safety.
Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs
R. Mathijssen,
T. van Gelder,
R. V. van Leeuwen,
2013,
British Journal of Cancer.
J. Meulenbelt,
H. Crommelin,
F. Jansman,
2015,
Drug Safety - Case Reports.
J. Aerts,
R. Mathijssen,
A. Reyners,
2017,
Clinical Pharmacokinetics.
M. Postma,
M. Rozenbaum,
E. Dvortsin,
2018,
BMC Cancer.
W. Vervenne,
H. Gelderblom,
C. V. van Herpen,
2019,
Clinical pharmacology and therapeutics.
E. V. van Roon,
N. Veeger,
M. Hoogendoorn,
2023,
Supportive Care in Cancer.
O. Visser,
A. Reyners,
N. Steeghs,
2022,
Seminars in oncology.
E. Smit,
C. H. van der Leest,
M. Deenen,
2023,
Targeted Oncology.
W. M. Smit,
D. Sleijfer,
J. Brouwers,
2005,
Clinical therapeutics.
W. Vervenne,
H. Gelderblom,
W. V. D. Graaf,
2019,
Journal of Clinical Oncology.
M. Postma,
J. Brouwers,
F. Jansman,
2012,
PharmacoEconomics.
M. Postma,
J. Brouwers,
P. Willemse,
2004,
Clinical therapeutics.
M. Postma,
J. Brouwers,
J. Stevanović,
2015,
PloS one.
K. Taxis,
W. Vervenne,
A. Reyners,
2023,
Clinical Pharmacokinetics.
P. Nieboer,
M. Otten,
F. Jansman,
2016,
Nederlands tijdschrift voor geneeskunde.
R. V. van Lingen,
L. de Jong-van den Berg,
J. Brouwers,
2008,
Obstetrical & gynecological survey.
R. Mathijssen,
T. van Gelder,
R. V. van Leeuwen,
2019,
Therapeutic advances in medical oncology.
Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs
F. Jansman,
D. Brundel,
T. V. Gelder,
2013,
British Journal of Cancer.
R. Mathijssen,
T. van Gelder,
R. V. van Leeuwen,
2014,
The Lancet. Oncology.
A. Rijneveld,
F. Jansman,
F. Piran,
2014,
Annals of oncology : official journal of the European Society for Medical Oncology.